The Beers criteria role in predicting bleeding during the use of direct oral anticoagulants in patients with atrial fibrillation over 80 years of age

The Beers criteria role in predicting bleeding during the use of direct oral anticoagulants in patients with atrial fibrillation over 80 years of age

Цель. Проанализировать лекарственную терапию пациентов с неклапанной фибрилляцией предсердий (ФП) 80 лет и старше для выявления частоты ненадлежащего назначения лекарственных средств (ЛС) согласно критериям Бирса и оценить их роль в прогнозировании клинически значимого небольшого кровотечения (КЗНК)...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. S. Cherniaeva, M. A. Rozhkova, E. S. Ilyina, E. A. Moiseeva, E. A. Gorelov, L. A. Egorova, O. M. Maslennikova, N. V. Lomakin, D. A. Sychev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2025-04-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	beers criteria inappropriate drug prescribing elderly patients clinically relevant non-major bleeding atrial fibrillation direct oral anticoagulants bleeding prediction safety of direct oral anticoagulants pharmacosafety
Online Access:	https://www.rpcardio.online/jour/article/view/3157
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding
by: A. B. Sumarokov, et al.
Published: (2019-01-01)

Anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease and atrial fibrillation. Experience with Idarucizumab
by: L. A. Shpagina, et al.
Published: (2020-06-01)

Cerebral microbleeds in geriatric patients with non-valvular atrial fibrillation
by: M. S. Chernyaeva, et al.
Published: (2025-07-01)

Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy
by: N. V. Bakulina, et al.
Published: (2021-09-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)
by: E. I. Baranova, et al.
Published: (2020-02-01)

Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective Study
by: Caroline Arches, et al.
Published: (2025-04-01)

PERSONALIZED ANTICOAGULANTS: TAILORING THERAPY TO INDIVIDUAL PATIENT'S NEED
by: Sheikh Abdul Khaliq, et al.
Published: (2025-08-01)

Safety of DOACs in patients with Child‐Pugh Class C cirrhosis and atrial fibrillation
by: Mark Ayoub, et al.
Published: (2024-05-01)

Bleeding and thrombosis in intestinal transplantation; data from 145 consecutive adult transplants
by: Francesca Reeder, et al.
Published: (2025-07-01)

Evaluation of extended direct oral anticoagulant dosing strategies in patients with and without cancer from a prospective observational registry
by: Danielle T. Vlazny, et al.
Published: (2025-05-01)

Agreement between the 2009 STOPP Criteria and the 2003 Beers Criteria at the time of hospital admission
by: María Muñoz García, et al.
Published: (2016-12-01)

Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients?
by: N. M. Vorobyeva, et al.
Published: (2024-10-01)

Clinical characteristics, adherence to anticoagulation therapy and prognosis in patients with atrial fibrillation: a real-life study
by: Fenglin Qi, et al.
Published: (2025-04-01)

Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials
by: Christian Ovesen, et al.
Published: (2025-02-01)

Experience of using Beers criteria in clinical practice (according to Russian literature)
by: M. S. Cherniaeva, et al.
Published: (2024-11-01)

Analysis of Postoperative Bleeding After Oral Surgery in Patients Receiving Anticoagulants: A Retrospective Study
by: Jae-Il Lee, et al.
Published: (2025-02-01)

Hospitalizations for bleeding associated with apixaban versus rivaroxaban according to dose in Medicare beneficiaries
by: Luke S. Vest, et al.
Published: (2025-09-01)

Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis
by: Yifang Zhang, et al.
Published: (2024-12-01)

Temporal Changes in Long‐Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
by: Kazuhisa Kaneda, et al.
Published: (2024-08-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
by: N. Sh. Zagidullin, et al.
Published: (2021-10-01)

MANAGEMENT OF TOOTH EXTRACTIONS IN PATIENTS RECEIVING THE NEW ORAL ANTICOAGULANTS
by: L. Vladimirova-Kitova, et al.
Published: (2022-03-01)

Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City
by: A. A. Tuchkov, et al.
Published: (2019-03-01)

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis
by: Cornelia Ghea, et al.
Published: (2023-01-01)

Thrombodynamics Test in Assessing the Risk of Thrombus Formation in Patients with Atrial Fibrillation Taking Direct Oral Anticoagulants
by: Z. A. Gebekova, et al.
Published: (2022-11-01)

Risk of bleeding with dentoalveolar surgery in patients taking direct oral anticoagulants or vitamin K antagonists: A systematic review and meta-analysis
by: Ke Dou, et al.
Published: (2025-12-01)

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
by: Ola Ali, et al.
Published: (2024-12-01)

OPTIONS FOR USE OF APPROPRIATE ANTICOAGULANT THERAPY IN PATIENTS WITH THERMAL INJURY WITH A HIGH RISK OF THROMBOEMBOLIC COMPLICATIONS DEVELOPMENT ASSOCIATED WITH RECURRENT INTESTINAL BLEEDING
by: V. S. Borisov, et al.
Published: (2016-02-01)

Gastrointestinal Bleeding: a Cardiologist's Point of View
by: O. V. Averkov, et al.
Published: (2021-11-01)

Pathways for lower extremity superficial vein thrombosis management in an academic medical center
by: Gisoo Imani, et al.
Published: (2025-03-01)

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01)

Problematic points of anticoagulant therapy for atrial fibrillation in certain Russian regions in 2016- 2019: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2024-10-01)

Endoscopic Procedures In Patients Taking Novel Oral Anticoagulants
by: Raluca Anica IONESCU, et al.
Published: (2021-09-01)

Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
by: E. A. Naryshkina, et al.
Published: (2025-06-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01)

Comparative clinical outcomes of acenocoumarol versus direct oral anticoagulants (DOACs) and warfarin in patients with atrial fibrillation: real-world-evidence (SIESTA-A study)
by: Ma Carmen Montero-Balosa, et al.
Published: (2025-08-01)

Oral anticoagulant periprocedural management in patients undergoing an oral, dental implant or periodontal surgery: a prospective national observational survey
by: Isabelle Mahé, et al.
Published: (2025-03-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)